International Stem Cell Corp (ISCO)
0.065
-0.01
(-8.71%)
USD |
OTCM |
Apr 24, 16:00
International Stem Cell Gross Profit Margin (Quarterly): 54.31% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.31% |
| September 30, 2023 | 60.42% |
| June 30, 2023 | 61.27% |
| March 31, 2023 | 60.50% |
| December 31, 2022 | 53.25% |
| September 30, 2022 | 59.48% |
| June 30, 2022 | 64.58% |
| March 31, 2022 | 64.11% |
| December 31, 2021 | 60.12% |
| September 30, 2021 | 55.81% |
| June 30, 2021 | 57.99% |
| March 31, 2021 | 62.91% |
| December 31, 2020 | 56.44% |
| September 30, 2020 | 61.99% |
| June 30, 2020 | 60.32% |
| March 31, 2020 | 63.69% |
| December 31, 2019 | 49.38% |
| September 30, 2019 | 61.88% |
| June 30, 2019 | 63.08% |
| March 31, 2019 | 62.08% |
| December 31, 2018 | 62.48% |
| September 30, 2018 | 58.84% |
| June 30, 2018 | 63.96% |
| March 31, 2018 | 68.67% |
| December 31, 2017 | 66.12% |
| Date | Value |
|---|---|
| September 30, 2017 | 74.34% |
| June 30, 2017 | 73.27% |
| March 31, 2017 | 72.42% |
| December 31, 2016 | 73.08% |
| September 30, 2016 | 68.81% |
| June 30, 2016 | 73.59% |
| March 31, 2016 | 76.67% |
| December 31, 2015 | 71.84% |
| September 30, 2015 | 73.55% |
| June 30, 2015 | 71.57% |
| March 31, 2015 | 74.23% |
| December 31, 2014 | 69.46% |
| September 30, 2014 | 73.61% |
| June 30, 2014 | 74.24% |
| March 31, 2014 | 73.38% |
| December 31, 2013 | 69.28% |
| September 30, 2013 | 73.23% |
| June 30, 2013 | 77.42% |
| March 31, 2013 | 74.01% |
| December 31, 2012 | 74.74% |
| September 30, 2012 | 73.04% |
| June 30, 2012 | 70.36% |
| March 31, 2012 | 69.92% |
| December 31, 2011 | 56.08% |
| September 30, 2011 | 57.13% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
49.38%
Minimum
Dec 2019
64.58%
Maximum
Jun 2022
59.55%
Average
60.42%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 81.54% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 15.54% |
| Electromed Inc | 77.03% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -2.40% |
| Profit Margin (Quarterly) | -24.25% |
| Operating Margin (Quarterly) | -22.45% |
| Return on Net Operating Assets | -2.58% |